Petros Pharmaceuticals Announces Completion Of Human Factors Study, To Facilitate Patient's Access To Its Erectile Dysfunction Drug, Stendra Associated With The Company's Intended FDA Application For Prescription To OTC Switch
Benzinga Newsdesk - Dec 12, 2023, 10:04AM